Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man
- PMID: 12743670
- DOI: 10.1007/s00228-003-0575-5
Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man
Abstract
Objective: To investigate the usefulness of the 3-hydroxylation of quinine as a biomarker reaction for the activity of CYP3A4 in man and to study the interindividual variation in the metabolic ratio (MR), i.e. quinine/3-hydroxyquinine.
Methods: Data from a previous study (A) was used for determination of the MR of quinine in plasma and urine at different time points. In study B, 24 healthy Swedish subjects received 250 mg quinine hydrochloride first alone and later together with four other CYP probe drugs [losartan (CYP2C9), omeprazole (CYP2C19), debrisoquine (CYP2D6) and caffeine (CYP1A2)] administered on the same day. Plasma and urine samples were collected before quinine intake and 16 h thereafter and analysed for quinine and 3-hydroxyquinine using high-performance liquid chromatography. Plasma and/or urine were collected for the other probes at different time points. MRs of all the probes were determined and correlations to quinine MR were studied.
Results: In study A, the MR in plasma was stable over 96 h. The ratio increased from 5.8 to 12.2 (P=0.006) during co-administration with ketoconazole, whereas no significant difference (P=0.76) was observed during co-administration with fluvoxamine (from 5.8 to 6.0). In study B, there was no significant difference (P=0.36) between the mean MRs when quinine was given alone (4.7) or together with the four other drugs (4.5). There was a significant correlation between the MR of quinine and omeprazole sulphone formation (r=0.52, P<0.01), but not to the MRs of the other probes. There was a fivefold interindividual variability in the MR.
Conclusions: The MR of quinine in plasma or urine may serve as a stable measure of the activity of CYP3A4 in man. These results together with in vitro data show that quinine is also a specific CYP3A4 probe.
Similar articles
-
Metabolism and elimination of quinine in healthy volunteers.Eur J Clin Pharmacol. 2003 Sep;59(5-6):423-7. doi: 10.1007/s00228-003-0637-8. Epub 2003 Aug 12. Eur J Clin Pharmacol. 2003. PMID: 12920491 Clinical Trial.
-
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo.Clin Pharmacol Ther. 1999 Nov;66(5):454-60. doi: 10.1016/S0009-9236(99)70008-1. Clin Pharmacol Ther. 1999. PMID: 10579472 Clinical Trial.
-
Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.Br J Clin Pharmacol. 1997 Mar;43(3):245-52. doi: 10.1046/j.1365-2125.1997.00556.x. Br J Clin Pharmacol. 1997. PMID: 9088578 Free PMC article.
-
Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.Clin Pharmacol Ther. 2000 Aug;68(2):199-209. doi: 10.1067/mcp.2000.108532. Clin Pharmacol Ther. 2000. PMID: 10976551 Clinical Trial.
-
Impact of Tetrahydropalmatine on the Pharmacokinetics of Probe Drugs for CYP1A2, 2D6 and 3A Isoenzymes in Beagle Dogs.Phytother Res. 2016 Jun;30(6):906-14. doi: 10.1002/ptr.5608. Epub 2016 Mar 17. Phytother Res. 2016. PMID: 26990021 Review.
Cited by
-
Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.Br J Clin Pharmacol. 2019 Aug;85(8):1704-1709. doi: 10.1111/bcp.13953. Epub 2019 May 27. Br J Clin Pharmacol. 2019. PMID: 30945322 Free PMC article. Clinical Trial.
-
Functional characterization of a unique cytochrome P450 in Toxoplasma gondii.Oncotarget. 2017 Dec 6;8(70):115079-115088. doi: 10.18632/oncotarget.23023. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383143 Free PMC article.
-
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.Eur J Clin Pharmacol. 2007 Feb;63(2):173-9. doi: 10.1007/s00228-006-0230-z. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200836
-
Effect of dehusked Garcinia kola seeds on the overall pharmacokinetics of quinine in healthy Nigerian volunteers.J Clin Pharmacol. 2015 Mar;55(3):348-54. doi: 10.1002/jcph.414. Epub 2014 Dec 22. J Clin Pharmacol. 2015. PMID: 25328082 Free PMC article. Clinical Trial.
-
Influence of a Nigerian honey on CYP3A4 biotransformation of quinine in healthy volunteers.J Clin Pharm Ther. 2015 Oct;40(5):545-549. doi: 10.1111/jcpt.12303. Epub 2015 Jul 14. J Clin Pharm Ther. 2015. PMID: 26177778 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources